REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 185 filers reported holding REGENXBIO INC in Q2 2019. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $541,431 | -18.6% | 28,632 | -2.4% | 0.01% | -16.7% |
| Q4 2022 | $665,545 | +6.5% | 29,345 | +24.2% | 0.01% | 0.0% |
| Q3 2022 | $625,000 | -1.1% | 23,632 | -7.6% | 0.01% | 0.0% |
| Q2 2022 | $632,000 | -56.9% | 25,588 | -42.0% | 0.01% | -62.5% |
| Q1 2022 | $1,465,000 | -9.5% | 44,138 | -10.8% | 0.02% | -11.1% |
| Q4 2021 | $1,618,000 | -26.1% | 49,491 | -5.2% | 0.02% | -14.3% |
| Q3 2021 | $2,189,000 | +0.6% | 52,212 | -6.7% | 0.02% | +10.5% |
| Q2 2021 | $2,175,000 | -17.1% | 55,984 | -27.2% | 0.02% | -26.9% |
| Q1 2021 | $2,623,000 | -14.3% | 76,888 | +13.9% | 0.03% | -23.5% |
| Q4 2020 | $3,061,000 | +795.0% | 67,481 | +913.7% | 0.03% | +1033.3% |
| Q2 2019 | $342,000 | -14.9% | 6,657 | -5.0% | 0.00% | 0.0% |
| Q1 2019 | $402,000 | +49.4% | 7,009 | +9.4% | 0.00% | +50.0% |
| Q4 2018 | $269,000 | -46.6% | 6,404 | -4.0% | 0.00% | -33.3% |
| Q3 2018 | $504,000 | – | 6,670 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 839,139 | $35,177,000 | 6.39% |
| Sonic Fund II, L.P. | 188,786 | $7,914,000 | 4.47% |
| ArchPoint Investors | 297,355 | $12,465,000 | 3.73% |
| Redmile Group, LLC | 2,008,001 | $84,175,000 | 1.47% |
| RTW INVESTMENTS, LP | 1,845,366 | $77,358,000 | 1.17% |
| WS MANAGEMENT LLLP | 210,729 | $8,834,000 | 0.94% |
| FRAZIER MANAGEMENT LLC | 235,809 | $9,885,000 | 0.79% |
| Integral Health Asset Management, LLC | 55,000 | $2,306,000 | 0.66% |
| Sofinnova Investments, Inc. | 127,593 | $5,349,000 | 0.32% |
| HHLR ADVISORS, LTD. | 456,000 | $19,116,000 | 0.25% |